Cambridgeshire -- (MARKET WIRE) -- 05/23/2005 -- Press Release 23 May 2005 BioProgress plc (“BioProgress” or “the Company”) CEO Appointment BioProgress plc (AIM: BPRG; NASDAQ: BPRG), the provider of innovative delivery mechanisms for the pharmaceutical oral dosage markets, announces the appointment of Richard Trevillion as Chief Executive Officer. Mr Trevillion joined the Board as a Non-Executive Director in February 2005 and became interim Chief Executive at the end of April. He has a wide range of experience within the global healthcare and technology sectors, both as advisor and principal, and has been responsible for the development of a number of high growth technology businesses.
